Vascular Disorder

2

Review clinical trials related to Vascular Disorder. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care

Several Drugs used in routine care in oncology induce rare but often severe or fatal cardiovascular or metabolic side effects. This study will investigate, evaluate, report and treat the cardiovascular side effects of anticancer drugs, through a specific cardiovascular routine checkup and follow-up taking place in several Cardio-oncology programs throughout France. The different including centers will be: Assistance Publique - Hôpitaux de Paris (APHP.6: Pitié-Salpétrière, Saint Antoine and Tenon's hospitals, Paris, France).

Participants needed: 5,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Groupe Hospitalier Pitie-SalpetriereUpdated: Sep 11, 2026Locations: 3
Eligibility criteria

Suffering a cancer [+1]

None

Status: Recruiting

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

The goal of this clinical trial is to evaluate the safety, tolerability, and recommended Phase 2 Dose (RP2D) of KLN-1010 in patients with relapsed or refractory multiple myeloma.

Participants needed: 70
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Kelonia Therapeutics, Inc.Updated: Aug 28, 2026Locations: 11
Eligibility criteria

Participants must have relapsed and refractory multiple myeloma (RRMM) with meas... [+3]

Participants must not have known central nervous system (CNS) involvement with m... [+3]